benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide has been researched along with Breast Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anderson, LM; Dipple, A; Khan, QA | 1 |
1 other study(ies) available for benzo(g)chrysene-11,12-dihydrodiol-13,14-epoxide and Breast Cancer
Article | Year |
---|---|
Protease inhibitor-induced stabilization of p21(waf1/cip1) and cell-cycle arrest in chemical carcinogen-exposed mammary and lung cells.
Topics: Animals; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Carcinogens; Cell Cycle; Chrysenes; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Cysteine Proteinase Inhibitors; Dactinomycin; Epithelial Cells; Flow Cytometry; Gene Expression Regulation, Neoplastic; Glycoproteins; Humans; Lung; Mice; Nocodazole; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |